• HyperScribe T7 High Yield RNA Synthesis Kit Plus

  2026-09-03

  Build scalable RNA workflows for mRNA rescue, antisense RNA production, RNA interference experiments, and labeled probes with one high-yield T7 platform. The kit combines pre-supplemented polymerase chemistry with modified-nucleotide flexibility, helping researchers move from template design to functional RNA testing more efficiently.

• Pepstatin A: Translational Control of Cathepsin D

  2026-09-02

  A mechanistic and strategic guide to using Pepstatin A as an aspartic protease inhibitor for cathepsin D validation, endothelial ischemia/reperfusion research, viral protein processing, and osteoclast biology.

• Carfilzomib (PR-171): Proteostasis to Radiosensitization

  2026-09-02

  Carfilzomib (PR-171) illustrates how irreversible proteasome inhibition can convert proteostasis stress into a radiosensitization strategy. This thought-leadership analysis connects molecular mechanism, experimental design, competitive positioning, and translational limitations using recent evidence in esophageal squamous cell carcinoma.

• Pentoxifylline: From cAMP to Translational Control

  2026-09-01

  Pentoxifylline is more than a vascular research reagent: as a phosphodiesterase inhibitor, it connects cAMP regulation with cytokine suppression, ICAM-1 biology, and translational assay design. This thought-leadership article examines the mechanistic evidence, protocol considerations, cross-domain relevance, and strategic opportunities for inflammation researchers.

• Dacarbazine Assays: From Viability to Cell Killing

  2026-09-01

  Dacarbazine is an antineoplastic chemotherapy drug whose assay response can be misread when growth inhibition and cell death are treated as the same endpoint. This guide translates dissertation findings into a practical framework for interpreting DNA damage, timing, and cytotoxicity in melanoma, lymphoma, and sarcoma models.

• miR-18a, ALOXE3, and Ferroptosis in GBM

  2026-08-31

  The reference study defines a miR-18a/ALOXE3 regulatory axis that promotes glioblastoma by weakening ferroptotic cell death and increasing tumor-cell migration through lipid signaling. Its combination of human tumor analysis, genetic perturbation, lipid mediator profiling, and orthotopic modeling provides a mechanistic framework for connecting microRNA control with ferroptosis and invasive behavior.

• EZ Cap™ Firefly Luciferase mRNA: Assay Design

  2026-08-30

  EZ Cap™ Firefly Luciferase mRNA can serve as more than a luminescent endpoint: it is a practical instrument for separating delivery, translation, and biological-response effects. This guide integrates Cap1 chemistry, assay controls, and recent mRNA-LNP evidence to support more interpretable reporter experiments.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-08-29

  Build a two-readout assay that separates mRNA uptake from functional translation in the same sample. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) provides a practical benchmark for nanoparticle screening, macrophage studies, and localized gene-delivery optimization.

• 1-myristoylglycerophosphocholine: Assay Workflows

  2026-08-29

  Build reproducible lysophospholipid experiments with 1-myristoylglycerophosphocholine, from fibroblast activation models to smooth muscle assays. This guide combines defined reagent handling, dose-ranging, lipid signaling pathway analysis, and troubleshooting informed by pulmonary fibrosis research.

• Q-VD-OPh Workflows for Apoptosis Research

  2026-08-28

  Q-VD-OPh provides broad, cell-permeable caspase activity inhibition for dissecting apoptotic execution, validating senolytic assays, and supporting cell recovery after cryopreservation. This workflow-focused guide explains how to select controls, optimize exposure, interpret incomplete rescue, and extend the reagent into neurodegeneration and translational models.

• Mestranol and Reversible Lysosomal Stress in Microglia

  2026-08-28

  The reference study establishes zebrafish larvae as a live model for an acquired, reversible lysosomal storage–like state in microglia after mestranol exposure. Its results separate impaired intracellular digestion from phagocytic uptake and increased apoptosis, providing a useful framework for studying environmental estrogen neuroimmunotoxicity.

• Cytarabine and Cell-Death Phenotyping

  2026-08-27

  Cytarabine and AraC offer more than a DNA synthesis inhibition model: they can help researchers distinguish apoptotic stress from inflammatory necroptosis. This article translates viral RIPK3-degradation research into practical assay decisions for leukemia and cell-death studies.

• HotStart 2X Green qPCR Master Mix for RCC Studies

  2026-08-27

  Build a sensitive SYBR Green workflow for tracking LDHA-linked metabolism, HIF-1α signaling, and sunitinib response in renal cell carcinoma models. This guide combines hot-start specificity, melt-curve control, and practical validation steps for real-time PCR gene expression analysis, RNA-seq validation, and nucleic acid quantification.

• Maternal Deltamethrin Exposure and Hippocampal Ferroptosis

  2026-08-26

  The reference study links maternal deltamethrin exposure with impaired hippocampal learning and memory in male rat offspring through p53-associated ferroptosis and disrupted calcium homeostasis. Its integration of behavioral, histological, biochemical, and cell-based intervention data provides a mechanistic framework for studying developmental neurotoxicity while highlighting the need for cautious interpretation of pharmacological pathway inhibition.

• Bestatin as a Chemical Genetic Tool for Jasmonate Signaling

  2026-08-26

  Zheng and colleagues established bestatin as a chemical probe for jasmonate signaling rather than merely an aminopeptidase inhibitor. By combining gene-expression profiling, pathway-dependence tests, developmental phenotyping, and a bestatin-resistance screen, the study identified genetically separable responses and candidate loci for dissecting jasmonate biology in Arabidopsis.

453 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page